What We're Reading: Page 57
Industry reads hand-picked by our editors
May 14, 2024
-
FirstWord Pharma
Updated biosecurity bill would give US drugmakers until 2032 to end ties with suspect Chinese biotechs
-
Fierce Biotech
Novo Nordisk’s Hemlibra rival hits goals in Phase 3
-
Reuters
Merck stops testing combo drug for skin cancer as more patients discontinue
-
AP News
Will AI replace doctors who read X-rays, or just make them better than ever?
May 13, 2024
May 10, 2024
May 09, 2024
-
KFF Health News
Amgen Plows Ahead With Costly, Highly Toxic Cancer Dosing Despite FDA Challenge
-
Fierce Biotech
Sanofi CSO Frank Nestle is leaving
-
The Wall Street Journal
Neuralink’s First Brain-Chip Implant in a Human Appeared Flawless. There Was a Problem.
May 08, 2024
May 07, 2024
May 06, 2024
-
FirstWord Pharma
Pfizer taps Citi analyst Andrew Baum as strategy chief
-
Fierce Biotech
GlycoMimetics fails phase 3 blood cancer trial, sinking stock
-
Politico
‘They need to back off’: Farm states push back on Biden’s bird flu response
-
The Wall Street Journal
‘Green Shoots’ Grow Out of Control on Wall Street
Previous
